Antibiotics that interfere with translation, when combined, interact in diverse and difficult-to-predict 6 ways. Here, we demonstrate that these interactions can be accounted for by "translation bottlenecks": 7 points in the translation cycle where antibiotics block ribosomal progression. To elucidate the under-8 lying mechanisms of drug interactions between translation inhibitors, we generated translation bot-9 tlenecks genetically using inducible control of translation factors that regulate well-defined translation 10 cycle steps. These perturbations accurately mimicked antibiotic action and their interactions, support-11 ing that the interplay of different translation bottlenecks causes these interactions. We further showed 12 that the kinetics of drug uptake and binding together with growth laws allows direct prediction of a 13 large fraction of observed interactions, yet fails for suppression. Simultaneously varying two trans-14 lation bottlenecks in the same cell revealed how the dense traffic of ribosomes and competition for 15 translation factors results in previously unexplained suppression. This result highlights the importance 16 of "continuous epistasis" in bacterial physiology. 17 22 23
Introduction
Antibiotic Abbreviation IC 50 [µg/mL] Mode of action, notes Chloramphenicol CHL 1.55 ± 0.01 Binds in the vicinity of the peptidyl-transferase centre (PTC) on the 50S subunit; partially overlaps with the acceptor stem of tRNA on the A-site [Wilson, 2014] .
Lincomycin LCY 281 ± 3 Lincosamide antibiotic; binds next to PTC and interferes with peptide bond formation [Wilson, 2014] .
Erythromycin ERM 25.3 ± 0.2 Macrolide antibiotic that binds further down the nascent peptide exit channel ( Fig. 1B) , and physically blocks the egress of the newly synthesized peptide chain [Wilson, 2014] .
Kasugamycin KSG 127 ± 1 Aminoglycoside; interferes with translation initiation by destabilization of the initiator tRNA on the P-site [Schluenzen et al., 2006] .
Streptomycin STR 2.55 ± 0.01 Aminoglycoside; interferes with the tRNA binding on the A-site as it stabilizes the non-cognate tRNAs and consequently inhibits translocation. It additionally induces mistranslation [Blanchard et al., 2010] .
Tetracycline TET 0.321 ± 0.001 Interferes with the binding of aminoacyl-tRNA to the A-site [Tritton, 1977] .
Capreomycin CRY 23.6 ± 0.1 Inhibits translocation by binding to the interface between subunits and stabilization of the ribosome in the pretranslocation state of the ribosome.
It only binds the fully assembled ribosome [Stanley et al., 2010] . lation inhibitors. Third, we identified a previously unreported synergy between CRY and CHL. Some of 82 the observed general trends in the drug interaction network, in particular the prevalence of antagonism, 83 may be explained by a general physiological response to translation inhibition. 84 A number of the interactions we measured confirm previous reports. For example, synergy between 85 erythromycin (ERM) and tetracycline (TET) was observed before [Yeh et al., 2006; Russ and Kishony, 86 2018]. Additivity between CHL and TET was also reported; moreover, this interaction proved to be 87 highly robust to genetic perturbations [Chevereau and Bollenbach, 2015] . Globally, antagonism and 88 suppression are more common in the translation inhibitor interaction network than synergy, consistent 89 with a general prevalence of antagonistic interactions between antibiotics [Brochado et al., 2018] . 90 2.2 Growth-law based biophysical model correctly predicts some interactions 91 but fails to predict suppression 92 As a first step toward understanding the origin of the observed drug interactions, we developed a math-93 ematical model that predicts such interactions from the effects of the individual drugs alone. We gen-94 eralized a biophysical model for the effect of a single antibiotic on bacterial growth [Greulich et al., 95 2015] to the situation where two antibiotics are present simultaneously. The model consists of ordinary 96 differential equations taking into account passive antibiotic transport into the cell, binding to the ribo-97 some ( Fig. 2A,B) , dilution of all molecular species due to cell growth, and the physiological response of 98 the cell to the perturbation (Fig. 2C ). The latter is described by ribosomal growth laws [Scott et al., 2010; 99 Greulich et al ., 2015] , which quantitatively connect the growth rate to the total abundance of ribosomes 100 when growth rate is varied by the nutrient quality of media or by translation inhibitors. All parameters of 101 the model can be inferred from the dose-response curves of individual drugs (Fig. 2D) . 102 When two different antibiotics are present simultaneously, separate variables are needed to describe 103 ribosomes that are bound by either of the antibiotics individually or simultaneously by both ( Fig. 2A) . 104 In the absence of knowledge about direct molecular interactions on the ribosome (as for the pairs 105 of lankamycin and lankacidin or of dalfopristin and quinupristin [Harms et al., 2004; Belousoff et al., 106 2011]), we assumed that the antibiotic binding and unbinding rates are independent of any previously 107 bound antibiotic (Fig. 2B ). The resulting model makes direct predictions for drug interactions between 108 translation inhibitors using only parameters that are inferred from the individual drug dose-response with the experimental data ( Fig. 2E-iii) . 119 Other drug interactions clearly deviated from the model predictions. An example is the suppres-120 sive/antagonistic interaction between STR and KSG, which was predicted to be additive ( Fig. 2E-iv) . 121 Such clear deviations could originate from the direct molecular interactions of the drugs on the ribo-122 some, and thus be specific for every pair of drugs. Alternatively, these mechanisms could originate 123 from the multi-step structure of the translation cycle itself, making general predictions possible. In the 124 most complex cases, drug interactions could result from drug effects that are unrelated to the primary 125 drug target [Chevereau and Bollenbach, 2015] , in particular from effects on drug uptake or efflux [Lazar 126 lation processes ( Fig. 3B ): stabilization of the 50S subunit (der), initiation (infB), delivery of charged 139 tRNAs (tufA/B), release of GDP from elongation factors (tsf), translocation (fusA) and recycling of the 140 ribosomes (frr) [Rodnina, 2018] . Reducing translation factor expression by varying the inducer con-141 centration resulted in a gradual decrease in growth which stopped at almost complete cessation of 142 growth, reflecting the essentiality of translation factors (Fig. 3C , Methods and SI). Since the endoge-143 nous regulation of translation factors generally follows that of the translation machinery [Maaløe, 1979; 144 Gordon, 1970; Blumenthal et al., 1976; Furano and Wittel, 1975] , limiting the expression of a single 145 translation factor imposes a highly specific bottleneck as all other components get upregulated. Fur-146 thermore, any global feedback regulation is left intact as we removed the factor from its native operon. 147 These synthetic strains thus offer precise control over artificial translation bottlenecks that determine 148 the rates of different translation steps. 149 We next used these strains to assess the impact of bottlenecks on antibiotic efficacy. Accordingly, 150 we measured growth rates over a two-dimensional matrix of concentrations of inducer and antibiotic 151 for each of the six strains ( Fig. 3C ; Methods). To address if the action of the antibiotic is independent 152 of the translation bottleneck, we analyzed these experiments using a multiplicative null expectation. 153 Note that additivity as used for antibiotics (Fig. 1C) is not a suitable null expectation here since the 154 responses to increasing concentrations of antibiotic and inducer are opposite. However, if antibiotic 155 action is independent of the translation bottleneck, the growth rate should be a product of the relative 156 growth rates of each of the two perturbations acting individually. Independence implies that the dose- introduced to control the expression of a translation factor x, which creates an artificial bottleneck in translation at a well-defined stage; lacI codes for the Lac repressor, which represses the P LlacO-1 -promoter (Methods, [Lutz and Bujard, 1997] We quantified the magnitude of these effects by bottleneck dependency (BD) scores (Methods) and 164 collected them into a single bottleneck dependency vector per antibiotic. The components of this vector 165 describe the interaction between that antibiotic and all six translation bottlenecks. Bottleneck depen-166 dency vectors were diverse ( Fig. 3D ), indicating that bottlenecks at different stages of the translation 167 cycle differentially affect antibiotic efficacy. These results are consistent with the hypothesis that the 168 high diversity of drug interactions between translation inhibitors ( Fig. 1D ) originates in the diversity of 169 translation steps targeted by the drugs (Fig. 1A ).
170
The bottleneck dependency vector of a given antibiotic provides a quantitative, functional summary 171 of its interaction with the translation cycle. In this sense, it is a characteristic "fingerprint" of the antibiotic. STR has strong secondary effects: it causes protein mistranslation, changes in membrane potential, 206 and membrane permeabilization [Davis, 1987] . Some of these processes, in particular the production 207 of dysfunctional proteins, overlap with those of NIT [Bandow et al., 2003] , offering an explanation for the 208 observed similarity of these seemingly unrelated drugs. 209
Drug interactions can be predicted from antibiotic responses to translation
210 bottlenecks 211 We reasoned that the effects of translation bottlenecks on antibiotic action should also have predictive 212 power for drug interactions involving translation inhibitors. We thus sought for a quantitative way of prob-213 ing the contribution of translation bottlenecks to drug interactions between translation inhibitors. Trans-214 lation can be seen as a sequence of steps in which ribosomes progress through the protein production 215 cycle. Antibiotics and genetic translation bottlenecks hinder this progression similarly by reducing the 216 transition rates between such steps (Fig. 4A ). In cases where an antibiotic specifically targets a single 217 translation step and reduces the same transition rate as a genetic translation bottleneck, the antibiotic 218 effect and the genetic translation bottleneck should be equivalent perturbations, i.e., the consequences 219 of any perturbation elsewhere in the translation cycle should be independent of the exact means by 220 which such a reduction has been effected ( Fig. 4B ).
221
To establish the equivalence between translation bottlenecks and antibiotic action, we first trans-222 formed the measurements of growth rate as a function of translation factor induction into dose-response 223 curves of a corresponding idealized antibiotic that targets a single translation step with perfect specificity. 224 In essence, this procedure converts inducer concentrations into equivalent antibiotic concentrations: the 225 two concentrations are identified as equivalent if they lead to the same relative growth rate ( Fig. 4C demonstrating that an antibiotic acts as an equivalent perturbation to a specific translation factor pro-238 vides strong evidence for its primary mode of action, since translation factors are thought to control 239 individual steps with high specificity. 240 For antibiotics that are equivalent to specific translation factors ( Fig. 4F ), drug interactions with other 241 antibiotics can be directly explained and predicted. In practice, this is done by remapping the antibiotic-242 translation factor response surfaces as described above (Fig. 5A,B ). The resulting prediction will be 243 faithful if the drug interaction originates exclusively from the combination of two bottlenecks in the trans-244 lation cycle. Drug interactions predicted using this procedure were often highly accurate ( Fig. 5C ). In 245 particular, some of the most striking cases of antagonistic and suppressive interactions were correctly 246 predicted. For example, the suppressive interaction of CHL with FUS was correctly predicted, including 247 its direction: FUS loses potency when exposed to CHL ( Fig. 5C-i) . Further, the prediction of antagonism 248 between CHL and STR was qualitatively correct ( Fig. 5C -ii). Similarly, prediction of these interactions 249 with FUS and STR were also correct for LCY ( Fig. S5 ) which is similar to CHL (Fig. 3E ). The remapping 250 approach further correctly predicted the prevalent antagonism and suppression of the initiation inhibitor is lowered (smaller factor symbol), the rate of step 1 decreases (thinner arrows) and ribosomes queue in front of the bottleneck.
Bottom: the same rate is reduced by an antibiotic. The effects of factor deprivation and antibiotic action on growth are equivalent.
(C) Schematic of conversion of inducer concentration in (here for the translocation factor) into the mimicked antibiotic concentration c (here: CRY). For each inducer concentration in, the growth rate from the induction curve g(in) is determined and the same growth rate on the antibiotic dose-response curve y (c) is identified (gray dashed line); the inverse function of the dose-response curve yields the equivalent antibiotic concentration as c = y -1 (g(in)). explained by the interplay of the specific steps in the translation cycle that are targeted by the constituent 255 antibiotics. 256 Our approach further explained nontrivial additive interactions. In particular, the additive interaction 257 between CHL and TET is hard to rationalize: these antibiotics have completely different binding sites on 258 the ribosome. However, CHL and TET interacted similarly with translation bottlenecks (Fig. 3E ) and their 259 interaction was faithfully captured by the remapping approach ( Fig. 5C -iii). This observation suggests 260 that the action of CHL is largely equivalent to inhibiting tRNA delivery. As CHL binding interferes with a 261 distal end of tRNA on the A-site [Wilson, 2014] , this suggests that perturbation of tRNA dynamics is at 262 the heart of the drug interaction between TET and CHL. KSG and ERM constitute another antibiotic pair 263 that interacted additively and was clustered together. Remapping correctly predicted additivity between 264 KSG-ERM (SI); however, ERM does not directly inhibit initiation as does KSG (Table 1 ). Yet, it is likely 265 that the inability of ERM to inhibit translation when the nascent peptide chain is extended beyond a 266 certain length effectively leads to a functional equivalence, which results in additivity and co-clustering 267 of ERM and KSG. 268 For certain antibiotic pairs, the predictions based on equivalent translation bottlenecks failed to ex-269 plain the observed drug interactions (e.g., for LCY-CRY and CHL-CRY; SI), indicating that these in- 270 teractions have origins outside of the translation cycle. We expect that these cases are often due 271 to idiosyncrasies of the drugs, which will require separate in depth characterization in each case. In 283 We focused on the interactions between initiation inhibitors (such as KSG) and translocation inhibitors 284 (such as CRY, STR, FUS) as they were exclusively antagonistic or suppressive ( Fig. 1D ). Moreover, the 285 initiation inhibitor KSG alleviated a genetic translocation bottleneck and an initiation bottleneck in turn 286 suppressed the effect of the translocation inhibitor FUS (Fig. 3C ). These observations suggest that a 287 universal mechanism underlies the suppression between initiation and translocation inhibitors. 288 Thus, we constructed a synthetic strain that enables simultaneous independent control of initiation 289 and translocation factor levels. We integrated the initiation and translocation factors outside their native 290 loci under tight control of promoters inducible by IPTG and anhydrotetracycline (aTc), respectively, in 291 a strain in which their endogenous copies were deleted (Figs. 6A and S6; Methods). To maximize 292 the precision of induction that is achievable with different inducer concentrations, we put both factors 293 under negative autoregulatory control by chromosomally integrated repressors [Klumpp et al., 2009; 294 Scott et al., 2010]. The resulting strain showed no growth when at least one of the inducers was absent 295 but wild type growth was fully rescued in the presence of both inducers (Fig. 6B ). These observations 296 confirm that both translation factors are essential and show that their expression can be varied over 297 the entire physiologically relevant dynamic range, thus enabling quantitative genetic control of two key 298 translation processes. 299 Curtailing translation initiation suppresses the effect of a genetic translocation bottleneck. We de-300 termined the bacterial response to varying translocation and initiation factor levels by measuring growth 301 rates over finely resolved two-dimensional concentration gradients of both inducers. The resulting re-302 sponse surface clearly showed that inhibition of initiation alleviates the effect of translocation inhibition 303 (Figs. 6C and S6) . This phenomenon exactly mirrors the antibiotic-antibiotic (KSG-FUS, Fig. 1D ) and 304 bottleneck-antibiotic interactions (initiation-FUS, Fig. 3C ). Note that an all-or-nothing approach (Fig. 6B) , 305 which is analogous to common genetic epistasis measurements [Constanzo et al., 2010] , would miss 306 this suppressive effect, highlighting the importance of the quantitatively controlled perturbations we 307 used. Taken together, these data show that the interplay of translation initiation and translocation alone 308 is sufficient to produce strong suppression: dialing down initiation cranks up growth stalled by transloca-309 tion bottlenecks. The widespread suppression between antibiotics targeting initiation and translocation 310 is thus explained as a general consequence of the combined inhibition of specific translation steps 311 alone. 312 What is the underlying mechanism of the suppressive interaction between initiation and transloca-313 tion inhibitors? We hypothesized that this suppression results from alleviating ribosome "traffic jams" 314 that occur during translation of transcripts when the translocation rate is low (Fig. 6D ). The traf-315 fic of translating ribosomes that move along mRNAs can be dense [Mitarai et al., 2008] and when 316 a ribosome gets stuck (e.g., due to a low translocation rate), it blocks the translocation of subse-317 quent ribosomes. The resulting situation is similar to a traffic jam of cars on a road. Traffic jams 318 form due to asynchronous movement and stochastic progression of particles in discrete jumps, which 319 is a good approximation for the molecular dynamics of a translating ribosome. If particle progres-320 sion were deterministic and synchronous, no traffic jams would form. A classic model of queued 321 traffic progression, which can be applied to protein translation [MacDonald et al., 1968; MacDonald 322 and Gibbs, 1969] , is the Totally Asymmetric Simple Exclusion Process (TASEP) [Shaw et al., 2003; 323 Zia et al., 2011]. 324 We developed a variant of the TASEP that describes the traffic of translating ribosomes on mRNAs 325 and takes into account the laws of bacterial cell physiology. There are several differences between the 326 classic TASEP and translating ribosomes moving along a transcript. First, a ribosome does not merely 327 occupy a single site (codon), but rather extends over 16 codons [Kang and Cantor, 1985] . Second, the 328 total number of ribosomes in the cell is finite and varies as dictated by bacterial growth laws [Scott et al., 329 2010; Scott et al., 2014] . Third, translation steps are mediated by translation factors that bind to the ri-330 bosome in a specific state and push the ribosome into another state [Rodnina, 2018] . These transitions 331 are stochastic with rates that depend on the abundance of ribosomes in a specific state and on the abun-332 dance of translation factors available to catalyze the step. Thus, the initiation and translocation-attempt 333 rates, which are constants in the classic TASEP, depend on the state of the system. We formulated a Taken together, our framework mechanistically explains twenty out of twenty-eight observed drug 377 interactions ( Fig. 1, S2 , S5), as judged by highly stringent quantitative and statistical criteria (Methods). 378 Here, even the cases rejected as quantitatively different are insightful. For example, the remapping-379 based prediction of CHL-FUS interaction ( Fig. 5C- ]. We were unable to introduce kan R directly into the strain with P LlacO-1 driven frr; therefore, 614 we first performed the deletion in an auxiliary strain MG1655 ∆frr::kan R bearing the ASKA plasmid into the strains by generalized P1 transduction. All chromosomal modifications were validated by PCR. 625 The factor titration platform and the repressor operon were Sanger-sequenced at the integration junc-626 22 tions using PCR primers or a primer binding into the kan R promoter region (which is upstream of the 627 P LlacO-1 promoter prior the resolution). The final genotype for the strains bearing the factor titration 628 platforms is HG105 ∆galK::frt-P LlacO-1 -x ∆x::frt ∆intS::frt-P LlacO-1 -lacI, where x denotes the chosen 629 factor. These strains contained no plasmids and no antibiotic resistance cassettes but had a single 630 copy of a translation factor under inducible control. 631 To generate the strain with independently regulated initiation and translocation factors, we started 632 with a strain carrying a single infB copy driven by P LlacO-1 . Then, the negatively autoregulated tetR 633 repressor was integrated into the chromosome, followed by FLP resolvase-mediated resolution of the 634 selection marker. This enabled the integration of P LtetO-1 -driven fusA into the intS locus; resolution was 635 followed by the disruption of the endogenous copy of fusA. Furthermore, we introduced a negatively 636 auto-regulated lacI into the xylB locus. This yielded a marker-less strain with the two essential genes Supplementary Table S2 . All DNA modifying enzymes and Q5 641 polymerase used in PCR were from New England Biolabs.
Simultaneous titration of translation factors reveals robust suppression be-

tween translocation and initiation inhibition
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Growth rate assay and two-dimensional concentration matrices 643 Rich lysogeny broth (LB) medium, which at 37 • C supports a growth rate of 2.0 ± 0.1 h -1 , was used.
644
LB medium was prepared from Sigma Aldrich LB broth powder (L3022), pH-adjusted by adding NaOH 645 or HCl to 7.0 and autoclaved. Antibiotic stock solutions were prepared from powder stocks (for catalog 646 numbers, see Table S1) and IPTG were prepared by serial dilution (0.70-fold). Growth rates were determined as a best-fit slope 665 of a linear function fitted to the log-transformed photon counts per second. The detailed fitting procedure 666 and examples of growth curves are shown in Fig. S1 . The experimental and analysis procedure led to 667 reproducible measurements of growth rates between days (Fig. S1, ρ ≈ 0.86) . Two-dimensional gradi-668 ents were usually set up in a 12×16 matrix (across two 96-well plates). For the double factor titration 669 experiment the inducer gradients were set up across 6 plates to form a 24×24 grid.
670
Normalization of dose-response surfaces 671 All growth rates were normalized with respect to the average growth rate in drug-free medium [for 672 factor-titration strains at highest inducer concentration (5 mM 
Quantification of the drug interaction type and bottleneck dependency 690
Loewe interaction score 691 To quantify the drug interaction between a pair of antibiotics, we defined the Loewe interaction score as 692 LI = log g(x 1 , x 2 )dx 1 dx 2 g(x 1 , x 2 ) add dx 1 dx 2 ,
where g(x 1 , x 2 ) and g add (x 1 , x 2 ) are the measured and the predicted additive dose-response surfaces 693 over a 2D concentration field (x 1 , x 2 ), respectively. The score LI is a log-transformed ratio of volumes 694 underneath the dose-response surfaces. It is positive for antagonistic and suppressive interactions, 0 695 for perfectly additive, and negative for synergistic interactions. To avoid imposing arbitrary bounds for 696 classifying a measured interaction as synergistic or antagonistic/suppressive (rather than additive), we 697 performed smooth bootstrapping on a set of ideal additive response surfaces to establish a distribution of 698 interaction indices expected for perfectly additive but noisy surfaces. To achieve this, we generated ad-699 ditive dose-response surfaces for drugs with Hill steepness parameter n between 1.8 and 6.6 (obtained 700 as 10% and 90% percentiles of the steepnesses distribution for measured dose-response curves). We response curves (Fig. S3 ). Mathematically, this means that r x = y (c) and r y = g(in) for antibiotic 716 and inducer, respectively. In response space, the null-expectation is independence, i.e. the expected 717 response is a product of individual responses. Thus, we define the BD score as 718 BD = log r (r x , r y )dr x dr y r x r y dr x dr y .
(2)
This score is zero when the two perturbations (bottleneck and antibiotic) are independent; it is pos-719 itive or negative for alleviation and aggravation, respectively. As for the LI score, we evaluated the 720 independence interval of BD scores by bootstrapping the BD score for independent surfaces at given 
where r u , r b and r tot are concentrations of unbound, bound and total ribosomes. The constants κ t = 0.06 µM -1 h -1 , r min = 19.3 µM, r max = 65.8 µM and ∆r = r max -r min = 46.5 µM were experimentally determined in Refs. [Scott et al., 2010; Greulich et al., 2015] . Transport of antibiotic is captured by the average flux as J(a ex , a) = p in a ex -p out a, where p in and p out are influx and efflux rates, respectively, and a and a ex are the intracellular and external antibiotic concentration, respectively. The kinetics of binding of the antibiotic to the ribosome is given as f (r u , r b , a) = -k on a(r u -r min ) + k off r b , where k on and k off are binding and unbinding rates, respectively, and K D = k off /k on . The fraction of inactive ribosomes r min is assumed not to bind antibiotics [Greulich et al., 2015] . The following system of ordinary differential equations (ODEs) describes the kinetics of the system 
where λ * 0 = 2 p out κ t K D and IC * 50 = ∆r λ * 0 /(2p in ). This equation can be recast into
where c = a ex /IC 50 ,
Here, IC 50 is the concentration required to halve the growth rate (compared to zero drug) and we took 735 into account that IC 50 /IC * 50 = (α 2 + 1)/2α. Importantly, the dependence of the relative growth rate y on 736 the relative concentration c dramatically changes when α < α crit = 2/3 √ 3 ≈ 0.385, as Eq. (7) exhibits a 737 concentration interval in which growth rate has two stable solutions.
738
Pair of antibiotics When a pair of antibiotics is considered, additional ODEs are added to describe the binding of individual antibiotics to ribosomes (first binding step) as well as the simultaneous binding of two antibiotics to the already bound ribosome (second binding step):
In the system of Eqs. (9), the kinetic parameters and the transport flux and binding functions depend curves, we fixed k on = 100 µM -1 h -1 (which gave consistent results for all dose-response curves). For 751 each dose-response curve, we determined the optimized value of K D -this was required due to explicit 752 need of parameters in forward integration (Fig. S2 ). By constraining these parameters, we can calculate 753 the steady state solutions of Eqs. (9).
754
Clustering of bottleneck-dependency vectors 755 We performed clustering of BD vectors projected on a space of lower dimensionality. For dimensionality 756 reduction, we used Principal Component Analysis (PCA). We used the first three principal components 757 which explained η r ≈ 95.38% of variance. In this projected three-dimensional space, we performed 758 unsupervised agglomerative clustering (Mathematica function FindClusters) with cosine distance as a 759 measure of cluster cohesion. 760 We estimated the p-value of the observed clustering by bootstrapping. We used the Rand index (RI) 761 [Rand, 1971] as a criterion for evaluating the difference between clustering results. For example, if w 762 is the clustering obtained for the reshuffled sample and clustering w is obtained for PCA projection of 763 median bottleneck dependency vectors (shown in Figs. 3,S3 ), then the Rand index is
Here, ψ ij is 1 if the i-th and j-th data points are either inside or outside of the same cluster and zero 765 otherwise; the denominator is the total number of unique pairs between N elements. We generated 10 4 766 reshuffled datasets, evaluated RI for each dataset and calculated the cumulative distribution function. 767 We evaluated an empirical p-value as 768 p = 1 -CDF 1 -1 N(N -1)/2 ≈ 3 × 10 -4 ,
which is an estimate of the probability for obtaining the observed clustering of median BD vectors by 769 chance. The cluster areas shown in Fig. 3 were obtained by smooth bootstrapping of median BD 770 vectors for a given noise statistics, PCA projection and subsequent calculation of the minimal convex 771 hull (Mathematica function ConvexHullMesh). The additional response vectors for LAM, TMP and NIT 772 were PCA projected (using Mathematica function DimensionReduction obtained for the median values 773 of BD vectors). Note, that the plots in Fig. 3E show projections onto PC1,2 but clustering was performed 774 on first three principal components (Fig. S3 ).
775
Remapping 776 Our remapping procedure converts inducer concentrations in into the concentrations c of an idealized 777 antibiotic that precisely targets the translation step controlled by the titrated factor. This requires an 778 induction curve and a dose-response curve: The former is described by an increasing Hill function g(in), 779 and the latter by solving Eq. (7) for y . The conversion between concentrations is formally described 780 as c = y -1 (g(in)) at a given α, which can be arbitrarily chosen for the idealized antibiotic. When 781 α < α crit , the dose-response curve is bistable and has a region in which more than one response 782 will yield the same concentration -in these cases we consider only the concentration corresponding 783 to the highest stable growth rate as the other solutions are either unstable or will be outcompeted. 784 Further, higher inducer concentrations are remapped to lower antibiotic concentrations and an infinite 785 inducer concentration corresponds zero antibiotic concentration. As this is impractical, we considered 786 all mimicked concentrations (normalized with respect to IC 50 ) that are below 0.1 as equivalent to 0.
787
Regularization of surfaces 788
Strains containing the factor titration platform have mostly very similar antibiotic dose-response curves 789 as the wild-type at maximal inducer concentrations. However, to correct for small deviations, we 790 rescaled the antibiotic concentrations on the antibiotic-inducer grid. The shape of this transformation 791 is derived from equating the responses of two Hill functions with different steepnesses. Consider two 792
Hill functions with Hill exponents n WT and n t for WT and factor-titrating strain, respectively. Then, by 793 equating the responses captured by these Hill functions, we calculated the rescaled relative (with respect to IC 50 ) antibiotic concentrations as c a,t = c n t /n WT a,WT . We refer to this conversion as the "power-law 795 transform". Such regularized surface was then used in remapping.
796
Remapping-based equivalence 797 Factor deprivation is equivalent to the action of a specific antibiotic if both perturbations can substitute for 798 each other. Upon remapping the inducer concentration, the response surface for an equivalent inducer-799 antibiotic pair is transformed into an additive response surface. To determine if the deprivation of a 800 specific factor is equivalent to the action of a specific antibiotic, we performed the remapping in tandem 801 with bootstrapping. Bootstrapping assesses the effects of uncertainties in the remapping parameter 802 α (obtained from a fit to a drug dose-response curve), artifacts of the response surface over inducer-803 antibiotic grid and sampling, and inherent noisiness of growth rate determination. We first restricted 804 the dataset to data points with relative growth equal to 0 or above 0.1 with growth rate coefficient of 805 determination R 2 > 0.8. In each round of bootstrapping, the following steps are carried out:
806
• drawing of a remapping parameter α from a normal distribution, centered at the best-fit-value and 807 with standard deviation estimated from fitting, and remapping, 808
• drawing of a random sample from remapped data points that is of random size (between 75% and 809 100% of the data set),
810
• addition of Gaussian noise to the growth rates (estimated from the growth rate fit),
811
• calculation of the ideal additive surface at a given α for comparison, and 812
• calculation of LI score. 813 This procedure was repeated 100 times for each bottleneck-antibiotic pair and yielded a set of distri-814 butions. Each LI distribution was then statistically evaluated for being inside the additive interval. We 815 obtained the cumulative distribution function (CDF) for each distribution and we calculated its value on 816 both ends of additive interval (Fig. S1 ). If either 1 -CDF (b lower ) or CDF b upper is below p = 0.05, the 817 pair is considered inequivalent -this is the case in which the remapped surface is unlikely to be additive. 818 For each antibiotic, more than one of the bottlenecks could be statistically equivalent -we thus deemed 819 the bottleneck-antibiotic pair with the highest correlation between average remapped and ideal additive 820 growth rates to be the primary candidate for equivalence of perturbations.
821
Quantitative comparison of predicted and measured response surfaces 822 Both measured and predicted surfaces match along the individual concentration axes, as those were 823 obtained from the fits of dose-response curves. Thus, points corresponding to such measurements are 824 always a good match and in turn increase Pearson correlation invariantly of a potential mismatch in 825 surface segments further away from individual axes. We thus sought an applicable metric that would 826 identify systematic deviations from predicted isoboles. 827 We developed an "isobole sliding" method in which we determine a mean deviation of points close 828 to some predicted growth rate from measured values. It provides a concise quantitative description of 829 29 differences between predicted and measured isoboles and identifies the most discrepant areas of the 830 surfaces. For that we systematically move along the (ordered) predicted growth values g i and select 831 S = 20 consecutive points and average their deviations from measured values of growth rate h i . This 832 yields a deviation trajectory t(ĝ) of a mean deviation as a function of average predicted growth rate 833
Keeping the number of points S in the window fixed allows the comparison between different subsets of 834 the data. 835 To assess the probability of observing such deviation by chance, we created a benchmark dataset by 836 replacing all measured values with predicted ones to which we added Gaussian noise (estimated from 837 bootstrapped dispersion, but of at least 0.05 relative growth units To estimate the upper bound of prediction-measurement consistency, we checked for consistency 850 of the measured replicates. For this we considered one of the replicates as a prediction of the other. 851 Doing so, we observed that twenty-one out of twenty-eight (75%) surfaces act as statistically significant 852 predictions for one another. This serves as an approximate upper bound for how many predictions-853 measured pairs can be at most expected to match at the given experimental variability.
854
Assessment of predictive power 855 At this point we can assess the consistency of predictions. Using the method described above, we eval-856 uated both independent and competitive binding schemes for their congruence with measured surfaces. 857 The scheme that led to the distribution with the smallest mean maximal deviation, was considered as 858 best-match. However, both schemes can yield a good match -by asking how many of the schemes 859 yield a match in both replicates, we obtain an estimate for a fraction of correct predictions (Fig. S2 ). By 860 counting in how many cases at least one of the schemes yields a match between replicates, we find 861 that sixteen out of twenty-eight interactions can be accounted for by a biophysical model. 862 Applying isobole sliding to the prediction of remapping shows that even small quantitative deviations 863 will lead to discarding of the prediction (Fig. S5 ). However, counting additionally explained interactions 864 by remapping (TET-CRY, TET-FUS, KSG-CHL, CRY-KSG) increases the total tally of explained interac-865 tions to twenty out of twenty-eight (≈71.4%), which is below the estimated self-consistency bound of 866 75%. As discussed above, qualitative matches are not included in this metric. and J tran (ζ, γ) = γ
where ζ and γ are initiation and translocation attempt-rates, respectively. The ribosome (coverage) 884 density ρ reads:
and ρ tran (ζ, γ) = ρ max = 1
The elongation velocity u depends both on the current and the ribosome density ρ r = ρ/L via u = Js/ρ r , 886 where s is the step size (1 aa). This in turn yields
Distribution of ribosomes across different classes The total ribosome concentration r tot is 888 r tot = r i + r tr + r min ,
where r i and r tr are the concentrations of non-initiated and translating ribosomes, respectively. Trans-889 lating ribosomes are distributed across numerous mRNA transcripts in the cell and their concentration 890 can be written as:
where D p and ρ r ,p are the length and ribosome density of the p-th transcript, respectively, M is the 892 total number of transcripts and V the cell volume (Ξ = M/V is the concentration of transcripts). The 893 density of ribosomes ρ r = ρ/L is a TASEP-derived quantity and depends on the initiation attempt rate 894 α and translocation attempt rate γ. In the last step, we assumed for simplicity that the density of 895 ribosomes across the transcripts does not vary significantly between transcripts. However, if transcripts 896 do differ in their ribosomes densities, the ones with higher densities will enter the translocation limiting 897 regime (in which traffic jams form) already at a smaller decrease in translocation attempt rate. If those 898 transcripts code for essential genes, this will correspondingly lead to a decrease in growth rate already 899 at such smaller decreases in translocation attempt rate. Such traffic jams would still be relieved by 900 lowering initiation rate even though traffic jams have not developed on all other transcripts. Thus, the 901 qualitative conclusions of the analysis below would still hold, but the results would be quantitatively 902 different. However, taking differences between transcripts into account would require explicit modeling 903 of individual transcripts and is beyond the scope of this work. Assuming similar ribosomes densities 904 allows replacement of the sum with MD, whereD is the average length of transcripts being translated; 905 the proteome-weighted average length isD ≈ 209 [Milo and Phillips, 2016] . 906 The growth rate is proportional to the elongation velocity of ribosomes along the transcript u(α, γ) 907 and to the number of translating ribosomes. However, there is a limit for the maximal elongation rate 908 u max because other processes (e.g., charged tRNA delivery) become limiting at some point in a given 
However, the growth rate feeds back into the total ribosome concentration via the growth law as 916 r tot = r i + r tr + r min = r max -λ∆r
We can estimate Ξ at λ 0 as
Factor-dependent translocation attempt rate The ribosome will perform a specific step only when the associated factor is bound to it: the step-attempt rate is proportional to the probability P b of the ribosome being bound by a factor. This probability can be calculated by assuming a population of elongation factors with concentration c ef = c ef,b + c ef,n and translating ribosomes r tr = r tr,b + r tr,n , where the indices b and n denote the factor-bound and unbound subpopulations, respectively. Binding is described by dr tr,b dt = k on c ef,n r tr,n -k off r tr,b ,
Solving for steady state, noting that r tr,b = c ef,b and defining K D = k off /k on we obtain the probability for a 918 ribosome to be bound as 919 P b = r tr -r tr,n r tr = 1 -(r tr -K D -c ef ) + 4K d r tr + (r tr -K D -c ef ) 2 2r tr .
The binding constant of EF-G to the ribosome complex I (pre-translocation analog with N-Ac-dipeptidyl-920 tRNA at the A-site and deacylated-tRNA in the P-site) [Yu et al., 2009] as there are too many mRNAs that can carry more ribosomes than available. The critical unperturbed 962 ribosome density is ρ r,crit = λ 0 /(κ t ∆r ) × ρ r,max (Fig. S6 ).
963
Effect of mRNA growth-rate dependence 964 The concentration of mRNA could in principle be growth rate-dependent. However, direct dependence 965 of mRNA as a function of the growth rate is difficult to estimate from existing literature as total RNA 966 is mostly composed of rRNA and tRNA [Dai et al., 2016; Scott et al., 2010] ; estimation of the mRNA 967 fraction is thus prone to errors. However, if we assume proportionality between ribosome and mRNA 968 concentration, a simplified form can be written down as Ξ = Ξ 0 r tot /r tot,0 , where Ξ 0 and r tot,0 = r min +λ 0 /κ t 969 are the estimates of mRNA concentration from the previous section and total ribosome concentration 970 in the unperturbed case, respectively. Plugging this dependence into the model does not qualitatively 971 change the suppressive interaction between inhibition of initiation and translocation (Fig. S6) all 28 antibiotic pairs. Due to small, but systematic variability in concentrations between replicates done on different days, we rescaled concentration axes with respect to the IC 50 . Dose-response surfaces were smoothed using LOESS (Methods). Black and gray dots denote measured points from different experiments. Isoboles from duplicates are in high agreement; small deviations are caused by occasional outliers that skew the isoboles. As the dose-response surface was measured over a 12×16 grid, the duplicates change the drug axes (12×16→16×12) on different days to check for effects coming from spreading the measurements over different plates. (B) An example of growth curves over a 12×16 grid. Note, that here the concentrations change between wells in a geometric manner, i.e. the ratio between concentrations in neighboring wells is fixed. (C) Exemplary growth curve and details of the fitting procedure. The growth rate is determined by fitting a line in the regime of exponential growth. The determination of this regime in the growth curve is carried out automatically; procedure: (i) check if the maximum value of luminescence is above the lower bound of the fitting interval lum min = 10 3 cps and take points before the maximum, (ii) take points that are the latest to rise over lum min , (iii) determine the upper limit (bnd) of the fitting interval to be either ten-fold above the lum min (guaranteeing log 2 10 ≈ 3.3 doublings of fitting interval) or eight-times less than the track maximum (three doublings away Green check marks denote that LI did not fall outside of the additivity interval; in these cases, the rounded correlation ρ is reported. A good agreement with the additive expectation suggests equivalency of antibiotic and genetic perturbation. (B)
Examples of histograms of LI for CRY in combination with a translocation and recycling bottleneck [see matching pentagon and star in (A)], respectively. (C) Color-coded sequential evaluation of equivalence between bottleneck and translation inhibitor. Red and yellow denote that LI was outside or inside of the additive interval, respectively. From the cases in which the LI is statistically inside the additive interval, the case with highest correlation was chosen as the putative primary mode of action (green). This approach correctly identified the mode of action for all cases in which it is known from literature (CRY, FUS, STR, KSG and TET). Each prediction is evaluated for goodness of prediction as described in Methods. Check-mark and cross denote a match and mismatch, respectively. (E) Impact of varying the initial ρr on resulting bottleneck dependency score. Numbered green squares correspond to the examples showcased in (F). The white circle shows the result for the estimated value of WT ρr ≈ 0.042. The red circle shows the point (ρr ≈ 0.0106) where first derivative becomes positive and the BD score starts increasing. The solid vertical line shows the critical value λ 0 ρr,max/(κ t ∆r ) above which traffic jams due to translocation limitation can form. (F) Response surfaces for ρr values shown in (E). For ρr 0.01 the ridge line (red; defined by the concentration of initiation factor that supports the highest growth rate at a given concentration of translocation factor) is not well defined, and tends towards high concentrations of initiation factor.
For ρr > 0.1, the ridge line moves towards the "corner" of the response surface. After the value λ 0 ρr,max/(κ t ∆r ) is surpassed, traffic jams develop when the translocation rate is sufficiently low. (G) Two models of mRNA concentration dependence. Black lines denote the dependence of mRNA on growth rate if the co-regulation between total RNA and mRNA (Methods) is assumed;
solid and dashed lines correspond to variation of the nutrient quality and translation perturbation, respectively. The arrow denotes the estimated mRNA concentration for cells grown in LB (Methods); this concentration is assumed constant (dashed purple line)
in the model shown in the main text. If the mRNA concentration exceeds ∆r / ρmax,rD , traffic jams do not develop. Elongation factors are still sequestered as the number of translating ribosomes increases, which in turn decreases the growth rate. (H) Direct comparison of model predictions. Prediction with growth-dependent mRNA concentration Ξ is depicted in full gray-scale tones;
isoboles from the prediction assuming a constant pool of mRNA are shown in purple. Both results are qualitatively equivalent.
